| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.0074 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |